ORBIMED ADVISORS LLC 13D/13G Filings for Ascendis Pharma A/S (ASND)

ORBIMED ADVISORS LLC 13D and 13G filings for Ascendis Pharma A/S:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-05-22
4:54 pm
Sale		 2020-05-20 13D Ascendis Pharma A/S
ASND		 ORBIMED ADVISORS LLC 2,083,713
4.300%		 -435,069decrease
(-17.27%)		 Filing
2020-05-07
9:48 pm
Sale		 2020-05-05 13D Ascendis Pharma A/S
ASND		 ORBIMED ADVISORS LLC 2,518,782
5.200%		 -493,118decrease
(-16.37%)		 Filing